Break out with AstraZeneca and BCD at ITM Revive, April 28

Register for the ITM conference to gain access to a BCD panel on day 2 of the conference.

AstraZeneca Associate Director Kerrie Henshaw-Cox and BCD Travel experts will present at a virtual conference tackling COVID-related business travel issues pulled straight from today’s headlines. The session, “Beyond borders: How international trends impact the UK market,” will take place April 28, on the second day of the Institute of Travel Management’s Revive Conference.

Join the conversation

Revive ITM Conference | April 27-28 (virtual)
Save the date – Beyond borders: How international trends impact the UK market, April 28 at 1 p.m. CEST

Kerrie Henshaw-Cox, Associate Director, AstraZeneca
Kerrie Henshaw-Cox, Associate Director, AstraZeneca

Henshaw-Cox, who was named Travel Buyer of the Year at the 2019 Business Travel Awards, will join Tony McGetrick, vice president, Regional/Traditional Corporate Sales for BCD in the UK, and Mike Eggleton, BCD’s Director Research for the event. In 30 minutes, the panelists will cover:

  • How events in remote locations can have far-reaching global impact
  • A recap of where we are today in the pandemic vs where we started
  • How AstraZeneca is managing travel along with ever-changing global restrictions and what, if any cues, they’re taking from the market
  • The measures needed to restart travel: what business travelers are telling us about their expectations and the role vaccines play in reopening travel